Literature DB >> 17989719

Gene expression profiling suggests primary central nervous system lymphomas to be derived from a late germinal center B cell.

M Montesinos-Rongen1, A Brunn, S Bentink, K Basso, W K Lim, W Klapper, C Schaller, G Reifenberger, J Rubenstein, O D Wiestler, R Spang, R Dalla-Favera, R Siebert, M Deckert.   

Abstract

To characterize the molecular origin of primary lymphomas of the central nervous system (PCNSL), 21 PCNSLs of immunocompetent patients were investigated by microarray-based gene expression profiling. Comparison of the transcriptional profile of PCNSL with various normal and neoplastic B-cell subsets demonstrated PCNSL (i) to display gene expression patterns most closely related to late germinal center B cells, (ii) to display a gene expression profile similar to systemic diffuse large B-cell lymphomas (DLBCLs) and (iii) to be in part assigned to the activated B-cell-like (ABC) or the germinal center B-cell-like (GCB) subtype of DLBCL.

Entities:  

Mesh:

Year:  2007        PMID: 17989719      PMCID: PMC6053313          DOI: 10.1038/sj.leu.2405019

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  19 in total

1.  Genes@Work: an efficient algorithm for pattern discovery and multivariate feature selection in gene expression data.

Authors:  Jorge Lepre; J Jeremy Rice; Yuhai Tu; Gustavo Stolovitzky
Journal:  Bioinformatics       Date:  2004-02-05       Impact factor: 6.937

2.  A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma.

Authors:  George Wright; Bruce Tan; Andreas Rosenwald; Elaine H Hurt; Adrian Wiestner; Louis M Staudt
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-04       Impact factor: 11.205

3.  A uniform activated B-cell-like immunophenotype might explain the poor prognosis of primary central nervous system lymphomas: analysis of 83 cases.

Authors:  Sophie Camilleri-Broët; Emmanuelle Crinière; Philippe Broët; Vincent Delwail; Karima Mokhtari; Anne Moreau; Michèle Kujas; Martine Raphaël; Wafae Iraqi; Catherine Sautès-Fridman; Philippe Colombat; Khê Hoang-Xuan; Antoine Martin
Journal:  Blood       Date:  2005-09-08       Impact factor: 22.113

4.  Gene expression and angiotropism in primary CNS lymphoma.

Authors:  James L Rubenstein; Jane Fridlyand; Arthur Shen; Ken Aldape; David Ginzinger; Tracy Batchelor; Patrick Treseler; Mitchel Berger; Michael McDermott; Michael Prados; Jon Karch; Craig Okada; William Hyun; Seema Parikh; Chris Haqq; Marc Shuman
Journal:  Blood       Date:  2006-01-17       Impact factor: 22.113

5.  Reverse engineering of regulatory networks in human B cells.

Authors:  Katia Basso; Adam A Margolin; Gustavo Stolovitzky; Ulf Klein; Riccardo Dalla-Favera; Andrea Califano
Journal:  Nat Genet       Date:  2005-03-20       Impact factor: 38.330

6.  Absence of immunoglobulin class switch in primary lymphomas of the central nervous system.

Authors:  Manuel Montesinos-Rongen; Roland Schmitz; Cornelius Courts; Werner Stenzel; Dörte Bechtel; Gerald Niedobitek; Ingmar Blümcke; Guido Reifenberger; Andreas von Deimling; Berit Jungnickel; Otmar D Wiestler; Ralf Küppers; Martina Deckert
Journal:  Am J Pathol       Date:  2005-06       Impact factor: 4.307

7.  Interphase cytogenetic analysis of lymphoma-associated chromosomal breakpoints in primary diffuse large B-cell lymphomas of the central nervous system.

Authors:  Manuel Montesinos-Rongen; Reina Zühlke-Jenisch; Stefan Gesk; José Ignacio Martín-Subero; Carlo Schaller; Dirk Van Roost; Otmar D Wiestler; Martina Deckert; Reiner Siebert
Journal:  J Neuropathol Exp Neurol       Date:  2002-10       Impact factor: 3.685

8.  A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling.

Authors:  Michael Hummel; Stefan Bentink; Hilmar Berger; Wolfram Klapper; Swen Wessendorf; Thomas F E Barth; Heinz-Wolfram Bernd; Sergio B Cogliatti; Judith Dierlamm; Alfred C Feller; Martin-Leo Hansmann; Eugenia Haralambieva; Lana Harder; Dirk Hasenclever; Michael Kühn; Dido Lenze; Peter Lichter; Jose Ignacio Martin-Subero; Peter Möller; Hans-Konrad Müller-Hermelink; German Ott; Reza M Parwaresch; Christiane Pott; Andreas Rosenwald; Maciej Rosolowski; Carsten Schwaenen; Benjamin Stürzenhofecker; Monika Szczepanowski; Heiko Trautmann; Hans-Heinrich Wacker; Rainer Spang; Markus Loeffler; Lorenz Trümper; Harald Stein; Reiner Siebert
Journal:  N Engl J Med       Date:  2006-06-08       Impact factor: 91.245

9.  The molecular and phenotypic profile of primary central nervous system lymphoma identifies distinct categories of the disease and is consistent with histogenetic derivation from germinal center-related B cells.

Authors:  L M Larocca; D Capello; A Rinelli; S Nori; A Antinori; A Gloghini; A Cingolani; A Migliazza; G Saglio; S Cammilleri-Broet; M Raphael; A Carbone; G Gaidano
Journal:  Blood       Date:  1998-08-01       Impact factor: 22.113

10.  NCBI GEO: mining tens of millions of expression profiles--database and tools update.

Authors:  Tanya Barrett; Dennis B Troup; Stephen E Wilhite; Pierre Ledoux; Dmitry Rudnev; Carlos Evangelista; Irene F Kim; Alexandra Soboleva; Maxim Tomashevsky; Ron Edgar
Journal:  Nucleic Acids Res       Date:  2006-11-11       Impact factor: 16.971

View more
  48 in total

1.  Differential gene expression in central nervous system lymphoma.

Authors:  James L Rubenstein; Arthur Shen; Tracy T Batchelor; Cigall Kadoch; Patrick Treseler; Marc A Shuman
Journal:  Blood       Date:  2009-01-01       Impact factor: 22.113

Review 2.  Pathophysiology of retinal lymphoma.

Authors:  Sarah E Coupland; Chi Chao Chan; Justine Smith
Journal:  Ocul Immunol Inflamm       Date:  2009 Jul-Aug       Impact factor: 3.070

3.  Array-based DNA methylation profiling of primary lymphomas of the central nervous system.

Authors:  Julia Richter; Ole Ammerpohl; José I Martín-Subero; Manuel Montesinos-Rongen; Marina Bibikova; Eliza Wickham-Garcia; Otmar D Wiestler; Martina Deckert; Reiner Siebert
Journal:  BMC Cancer       Date:  2009-12-21       Impact factor: 4.430

4.  Genome-Wide Analysis Uncovers Novel Recurrent Alterations in Primary Central Nervous System Lymphomas.

Authors:  Esteban Braggio; Scott Van Wier; Juhi Ojha; Ellen McPhail; Yan W Asmann; Jan Egan; Jackline Ayres da Silva; David Schiff; M Beatriz Lopes; Paul A Decker; Riccardo Valdez; Raoul Tibes; Bruce Eckloff; Thomas E Witzig; A Keith Stewart; Rafael Fonseca; Brian Patrick O'Neill
Journal:  Clin Cancer Res       Date:  2015-05-19       Impact factor: 12.531

Review 5.  Primary central nervous system lymphoma: essential points in diagnosis and management.

Authors:  Semra Paydas
Journal:  Med Oncol       Date:  2017-03-17       Impact factor: 3.064

6.  BCL2 expression is associated with a poor prognosis independent of cellular origin in primary central nervous system diffuse large B-cell lymphoma.

Authors:  Keishi Makino; Hideo Nakamura; Naoki Shinojima; Jun-Ichiro Kuroda; Shigetoshi Yano; Yoshiki Mikami; Akitake Mukasa
Journal:  J Neurooncol       Date:  2018-07-02       Impact factor: 4.130

7.  Prognostic impact of B-cell lymphoma 6 in primary CNS lymphoma.

Authors:  Stephan Kreher; Korinna Jöhrens; Felicitas Strehlow; Peter Martus; Kathrin Borowiec; Josefine Radke; Frank Heppner; Patrick Roth; Eckhard Thiel; Torsten Pietsch; Michael Weller; Agnieszka Korfel
Journal:  Neuro Oncol       Date:  2015-03-26       Impact factor: 12.300

Review 8.  [Differential diagnosis of lymphoid infiltrates in the central nervous system: experience of the Network Lymphomas and Lymphomatoid Lesions in the Nervous System].

Authors:  W Brück; A Brunn; W Klapper; T Kuhlmann; I Metz; W Paulus; M Deckert
Journal:  Pathologe       Date:  2013-05       Impact factor: 1.011

9.  New developments in the pathology of malignant lymphoma: a review of the literature published from January to April 2008.

Authors:  J Han J M van Krieken
Journal:  J Hematop       Date:  2008-07       Impact factor: 0.196

Review 10.  LMO2 and BCL6 are associated with improved survival in primary central nervous system lymphoma.

Authors:  Chen Lossos; Soley Bayraktar; Elizabeth Weinzierl; Sheren F Younes; Peter J Hosein; Robert J Tibshirani; Jocelyn Sutton Posthumus; Lisa M DeAngelis; Jeffrey Raizer; David Schiff; Lauren Abrey; Yasodha Natkunam; Izidore S Lossos
Journal:  Br J Haematol       Date:  2014-02-26       Impact factor: 6.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.